|
|
|
|
|
 |
Home |
 | |
 |
Calendar |
| |
|
Video |
| |
|
FAQs |
| |
|
Resources |
| |
| Upcoming Special Events | | |
|
|
|
|
Thank you to Providence Saint Joseph Foundation for providing funding for this site.
For more information about funding opportunities please contact the Foundation at
818-847-4673.
To earn CME Credits, please read our FAQ's.
I have read the FAQ's and need to Register.
I'm registered and need to LOGIN.
The AMA now requires that enduring materials, such as the Providence CME website, provide an assessment of the learner that measures achievement of purpose/objectives with minimum performance level required for credit. Therefore, a post-test must now be completed in order to receive AMA PRA Category 1 Credit™ for viewing videos on this site.
A score of 3 out of 3 or 100% answered correctly will be required to receive credit. Changes are effective for all activities that occur or are released on or after July 1, 2011.
Providence Saint Joseph Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Please note: CME credit for videos expires one year after posting date, unless otherwise noted.
A bibliography for each topic is available by contacting the Health Science Library at 818-847-3822 .
|
|
New Diabetes Medications: What you need to know during hospitalization
TUESDAY, June 20, 2017
12:15pm–Hope Conference Center
NEW DIABETES MEDICATIONS: WHAT YOU NEED TO KNOW DURING HOSPITALIZATION
DAVID KAYNE, MD
PROVIDENCE TARZANA MEDICAL CENTER
MODERATOR:
Irvin Benowitz, DO, Member, Medical Education Committee, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Kayne states he is on the Speakers Bureau for Eli Lilly, Sanofi, Mannkind, Novo Nordisk, Jansen, Astra-Zeneca, and Boehringer Ingelheim. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation. Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
|
|
6/20/2017
|
|
David
Kayne,
MD.
|
|
Presenter
|
|
Hope Conference Center
|
|
|
Complete Video Confirmation
In order to complete the evaluation, you must log in.
|
|
Multiple Sclerosis 2017 update
|
|
THURSDAY, June 15, 2017
12:15pm–Hope Conference Center
MULTIPLE SCLEROSIS:
2017 UPDATE
RICHARD SHUBIN, MD
PROFESSOR, CLINICAL NEUROLOGY, USC
PLANNER/MODERATOR:
Lin LeMay, MD, Chair, Neurology Section, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. LeMay states she has no financial relationships with a commercial company to disclose. Dr. Shubin discloses he is on the Speakers Bureau for Viogen, Teva, Sanofi, Acorda, UBC, Pfizer, Genentech, Novartis and Jazz Pharmaceuticals. He has received research support from Teva, Amgen, Sanofi, and Novartis. It is our policy to review disclosure forms ahead of time in order to identify and resolve any potential conflicts of interest. All potential conflicts were identified and resolved after review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
|
|
|
|
|
|
|
|
|
|
|
|
|